Health & Personal Care
HIGH
FDA DRUG
Ascend Laboratories Recalls ARIPIPRAZOLE 10 mg Tablets Over Superpotent Drug Risks (2025)
Ascend Laboratories, LLC recalls 2,256 bottles of ARIPIPRAZOLE 10 mg tablets distributed nationwide after discovering the product to be superpotent. The recall involves ARIPIPRAZOLE tablets manufactured by Alken Laboratories Ltd. in India and distributed in the United States. The recall date is August 28, 2025, with consumer notification by letter and guidance to stop use.
ARIPIPRAZOLE
Superpotent drug